The price of naloxone, the life-saving medication which may reverse an opioid overdose, has increased sharply over the past few years. From 2009 to 2014 the prices have increase by nearly 600 percent. The Senate Aging Committee is demanding answers from Pfizer, one of the colossal pharmaceutical companies producing the medication. How do these large pharmaceutical companies decide on these prices? How do they come to the decision for when it’s time to raise prices? Read Pfizer’s response and the full article by Clicking Here.